Rosemary Oil Inhalation: TLR4/NF-κB Targeted Relief forCOPD Inflammation & Mucus Hypersecretion | Blue Eyes Biotech
Title:
Rosemary Oil Inhalation: TLR4/NF-κB Targeted Relief forCOPD Inflammation & Mucus Hypersecretion | Blue Eyes Biotech
Meta Description:
Preclinically validated rosemary oil for COPDtherapeutics. Reduces airway inflammation & mucus via TLR4/NF-κBsuppression. GMP, nebulizer-ready. Request animal study data & formulationsupport!
---
Breakthrough Respiratory Support: Science-BackedRosemary Oil for COPD Pathophysiology Management
Chronic airway inflammation and mucusobstruction drive COPD progression, creating urgent need for targetedphytotherapeutics. Blue Eyes Biotech delivers standardized Rosemary EssentialOil (Rosmarinus officinalis) – proven in preclinical COPD models tosignificantly:
▼ SuppressTLR4/NF-κB PathwayActivation:
- 68% ↓ TLR4 expression in alveolar macrophages
- 54% ↓ p-IκBα phosphorylation vs. control
▼ AlleviatePathological Hallmarks:
- 72% ↓ neutrophil infiltration (BALF analysis)
- 61% ↓ MUC5AC protein overexpression
- 39% ↓ IL-8/TNF-α in lung tissue
---
Mechanism-Driven Applications:
> Pharmaceutical Inhalants:
-Nebulized solutions for acute exacerbations
-Dry powder inhalers (DPI) for maintenance therapy
> Medical Devices:
-Phytotherapeutic cartridges for portable nebulizers
-Hospital-grade respiratory therapy systems
> Nutraceuticals:
-Immune-modulating respiratory support blends
---
Technical Excellence:
✅ Active Profile:
-1,8-Cineole ≥35% (primaryanti-inflammatory)
- α-Pinene ≥12% (mucolytic synergy)
✅ Delivery-Optimized Formats:
-Sterile-filtered liquid for nebulization (EU Ph. grade)
-Lyophilized powder for DPI compatibility
-β-cyclodextrin complexes for sustained release
✅ Preclinical Validation:
-28-day COPD rat model: 48% improved lung function (FEV0.3/FVC)
-Ex vivo human bronchial tissue: 57% reduced goblet cell hyperplasia
---
Formulation Advantages:
• ParticleSize Control: <5μm for deep alveolar delivery (laser diffractionverified)
• OxidationStability: Nitrogen-flushed vials prevent terpene degradation
• SynergyPotential: Combines with N-acetylcysteine or glycopyrrolate
---
Why Pharmaceutical Partners Choose Us:
cGMP Manufacturing: ISO 13485 compliantfor inhaled products
Batch-Specific TLR4 Inhibition Assays:Cell-based potency testing
Sustainable Sourcing: Ecocert organicSpanish rosemary
Regulatory Support:
-FDA DMF Type IV (inactive ingredient)
-EMA traditional herbal registration data
-ICH stability protocols
---
Resource Package for Developers:
→ Downloadfull COPD rat model histopathology slides
→ Requestinhalation formulation technical dossier
→ Access GLPsafety/toxicology reports
Request Free Preclinical Data &Samples:
Contact: [email protected]
Product Page: www.blueeyes-bio.com
